Central Trust Co (CTTC) 0.2250 $CTTC
InnerWorkings (INWK) in Focus: Stock Jumps 5.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 23, 8:18AM CST
InnerWorkings Inc. (INWK) was a big mover last session, as the company saw its shares rise over 5% on the day.
INWK: 6.29 (+0.69)
L.B. Foster Boosts Inorganic Growth on TEW Engineering Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 20, 4:39PM CST
Premium railroads manufacturing company L.B. Foster Co. (FSTR) has recently strengthened its automated and international solutions' trade with the acquisition of TEW Engineering Ltd.
FSTR: 49.21 (+0.06), MTL: 1.48 (+0.14), CCRN: 11.13 (-0.28)
Calmare Therapeutics to Present at the Ld Micro "Main Event" Microcap Growth Conference
ACCESSWIRE - Wed Dec 03, 9:26AM CST
Fairfield, CT / ACCESSWIRE / December 3, 2014 / Calmare Therapeutics Incorporated, (OTCQX: CTTC) (CTI), the pain mitigation company, will present at the 7th Annual LD Micro "Main Event" Micro-Cap Growth Conference on Thursday, December 4 at 7:30 AM PT/10:30 AM EST. The conference will be held at the Luxe Sunset Bel Air Hotel, in Los Angeles, California.
Calmare Therapeutics Reports Third Quarter 2014 Results
ACCESSWIRE - Fri Nov 21, 2:57PM CST
Investor Conference Call: Monday, November 24, 2014 at 10:00 a.m. EST Dial-in: (866) 952-1908 | Conference ID: CTI
Conrad F. Mir, CEO of Competitive Technologies (OTCQX: CTTC) to Be Interviewed LIVE on Clear Channel Business Talk Radio -- August 14th, 2014
Marketwire - Wed Aug 13, 6:15AM CDT
Competitive Technologies, Inc (OTCQX: CTTC) (CTI) announced today that Chief Executive Officer (CEO) Conrad F. Mir will be interviewed live tomorrow by host Michael Yorba on Clear Channel Business Talk Radio's The Traders Network Show. Mr. Mir will be discussing Competitive Technologies Inc., the pain mitigation company, which develops and commercializes innovative pain management products and technologies. CTI holds the 510k clearance on its flagship product, the non-invasive Calmare(R) Pain Therapy Device. CTI is the exclusive licensed global distributor of Calmare.
CTT: 11.50 (+0.02)
Competitive Tech Brings Sales Management Position In-house
PR Newswire - Mon Aug 11, 1:22PM CDT
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), names William Lipford, the current Midwest Regional Sales Manager for CTI, U.S. division head of product sales. In his new role, he will be responsible to direct all U.S. sales of CTI's flagship product, the Calmare® Pain Therapy device, and oversee the expansion of CTI's independent, distributor sales force across the United States.
CTT: 11.50 (+0.02)
SeeThruEquity Initiates Coverage on Competitive Technologies (OTCQX:CTTC) with a Speculative Buy Rating - Video Research Alert on InvestmentPitch.com
Thomson Reuters ONE - Thu Jul 03, 9:36AM CDT
Vancouver, BC, July 3, 2014 - New York-based SeeThruEquity has initiated coverage on Competitive Technologies (OTCQX:CTTC). Analyst Brandon Primack gives the company a speculative buy rating, and a target price of $0.79, a premium of 147% to the $0.32 price on June 26th, the day the report was issued.
Judge Ruling Favors Calmare® Pain Therapy Reimbursement In Personal Injury Case Against Allstate Insurance Co.
PR Newswire - Mon Jun 30, 8:32AM CDT
The Calmare® Pain Therapy Device, the flagship product of Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), the pain mitigation company, gained a favorable reimbursement ruling from the New York City Civil Courts in a personal injury case against Allstate Insurance, Co., (Allstate). In the ruling, the Court instructed the insurance giant to reimburse Forest Rehabilitation Medicine P.C. (Forest) for its use of Calmare pain therapy (Calmare) on patients who suffer pain as a result of car accident injuries.
CTT: 11.50 (+0.02)
SeeThruEquity Initiates Research Coverage on Competitive Technologies Inc. with Target Price of $0.79
ACCESSWIRE - Thu Jun 26, 8:02AM CDT
New York, NY / ACCESSWIRE / June 26, 2014 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has initiated coverage on Competitive Technologies Inc. (OTCQX: CTTC), a pain mitigation company with innovative wound and pain management products and technologies.
Pipeline Mosque Inaugurates Africell-Sponsored Minaret
All Africa Global Media - Tue Feb 25, 11:05AM CST
The Pipeline Mosque on Friday inaugurated its new 33.35 meters minaret, reportedly sponsored by Africell GSM Company to the tune of D1 million.
CTT: 11.50 (+0.02)
Noka Resources Closes Oversubscribed Second Tranche of Financing
Marketwire - Tue Feb 25, 8:05AM CST
Noka Resources Inc. (TSX VENTURE: NX)(FRANKFURT: 2NK) (the "Company"
is pleased to announce that, further to the Company's news release dated February 6, 2014 whereas the Company closed $597,500 of the Non-Brokered Private Placement financing (the "Financing" , the Company has closed the second tranche of the Financing for additional gross proceeds of $536,000, bringing the total amount raised to $1,133,500.
NX.VN: 0.135 (+0.015), CTT: 11.50 (+0.02)
InnerWorkings (INWK) in Focus: Stock Jumps 5.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 23, 8:18AM CST
InnerWorkings Inc. (INWK) was a big mover last session, as the company saw its shares rise over 5% on the day.
INWK: 6.29 (+0.69)
L.B. Foster Boosts Inorganic Growth on TEW Engineering Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 20, 4:39PM CST
Premium railroads manufacturing company L.B. Foster Co. (FSTR) has recently strengthened its automated and international solutions' trade with the acquisition of TEW Engineering Ltd.
FSTR: 49.21 (+0.06), MTL: 1.48 (+0.14), CCRN: 11.13 (-0.28)
Calmare Therapeutics to Present at the Ld Micro "Main Event" Microcap Growth Conference
ACCESSWIRE - Wed Dec 03, 9:26AM CST
Fairfield, CT / ACCESSWIRE / December 3, 2014 / Calmare Therapeutics Incorporated, (OTCQX: CTTC) (CTI), the pain mitigation company, will present at the 7th Annual LD Micro "Main Event" Micro-Cap Growth Conference on Thursday, December 4 at 7:30 AM PT/10:30 AM EST. The conference will be held at the Luxe Sunset Bel Air Hotel, in Los Angeles, California.
Calmare Therapeutics Reports Third Quarter 2014 Results
ACCESSWIRE - Fri Nov 21, 2:57PM CST
Investor Conference Call: Monday, November 24, 2014 at 10:00 a.m. EST Dial-in: (866) 952-1908 | Conference ID: CTI
Conrad F. Mir, CEO of Competitive Technologies (OTCQX: CTTC) to Be Interviewed LIVE on Clear Channel Business Talk Radio -- August 14th, 2014
Marketwire - Wed Aug 13, 6:15AM CDT
Competitive Technologies, Inc (OTCQX: CTTC) (CTI) announced today that Chief Executive Officer (CEO) Conrad F. Mir will be interviewed live tomorrow by host Michael Yorba on Clear Channel Business Talk Radio's The Traders Network Show. Mr. Mir will be discussing Competitive Technologies Inc., the pain mitigation company, which develops and commercializes innovative pain management products and technologies. CTI holds the 510k clearance on its flagship product, the non-invasive Calmare(R) Pain Therapy Device. CTI is the exclusive licensed global distributor of Calmare.
CTT: 11.50 (+0.02)
Competitive Tech Brings Sales Management Position In-house
PR Newswire - Mon Aug 11, 1:22PM CDT
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), names William Lipford, the current Midwest Regional Sales Manager for CTI, U.S. division head of product sales. In his new role, he will be responsible to direct all U.S. sales of CTI's flagship product, the Calmare® Pain Therapy device, and oversee the expansion of CTI's independent, distributor sales force across the United States.
CTT: 11.50 (+0.02)
SeeThruEquity Initiates Coverage on Competitive Technologies (OTCQX:CTTC) with a Speculative Buy Rating - Video Research Alert on InvestmentPitch.com
Thomson Reuters ONE - Thu Jul 03, 9:36AM CDT
Vancouver, BC, July 3, 2014 - New York-based SeeThruEquity has initiated coverage on Competitive Technologies (OTCQX:CTTC). Analyst Brandon Primack gives the company a speculative buy rating, and a target price of $0.79, a premium of 147% to the $0.32 price on June 26th, the day the report was issued.
Judge Ruling Favors Calmare® Pain Therapy Reimbursement In Personal Injury Case Against Allstate Insurance Co.
PR Newswire - Mon Jun 30, 8:32AM CDT
The Calmare® Pain Therapy Device, the flagship product of Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), the pain mitigation company, gained a favorable reimbursement ruling from the New York City Civil Courts in a personal injury case against Allstate Insurance, Co., (Allstate). In the ruling, the Court instructed the insurance giant to reimburse Forest Rehabilitation Medicine P.C. (Forest) for its use of Calmare pain therapy (Calmare) on patients who suffer pain as a result of car accident injuries.
CTT: 11.50 (+0.02)
SeeThruEquity Initiates Research Coverage on Competitive Technologies Inc. with Target Price of $0.79
ACCESSWIRE - Thu Jun 26, 8:02AM CDT
New York, NY / ACCESSWIRE / June 26, 2014 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has initiated coverage on Competitive Technologies Inc. (OTCQX: CTTC), a pain mitigation company with innovative wound and pain management products and technologies.
Pipeline Mosque Inaugurates Africell-Sponsored Minaret
All Africa Global Media - Tue Feb 25, 11:05AM CST
The Pipeline Mosque on Friday inaugurated its new 33.35 meters minaret, reportedly sponsored by Africell GSM Company to the tune of D1 million.
CTT: 11.50 (+0.02)
Noka Resources Closes Oversubscribed Second Tranche of Financing
Marketwire - Tue Feb 25, 8:05AM CST
Noka Resources Inc. (TSX VENTURE: NX)(FRANKFURT: 2NK) (the "Company"
is pleased to announce that, further to the Company's news release dated February 6, 2014 whereas the Company closed $597,500 of the Non-Brokered Private Placement financing (the "Financing" , the Company has closed the second tranche of the Financing for additional gross proceeds of $536,000, bringing the total amount raised to $1,133,500. NX.VN: 0.135 (+0.015), CTT: 11.50 (+0.02)
